Loading...
XSES
C05
Market cap39mUSD
Aug 03, Last price  
0.66SGD
1D
-2.96%
1Q
29.70%
Jan 2017
-7.75%
Name

Chemical Industries (Far East) Ltd

Chart & performance

D1W1MN
XSES:C05 chart
P/E
—
P/S
0.82
EPS
—
Div yield, %
0.74%
Shrs. gr., 5y
—
Rev. gr., 5y
-0.76%
Revenues
61m
-7.25%
100,364,000105,141,00098,371,00092,996,000109,472,000107,009,000111,841,000100,162,00086,739,00078,390,00058,128,00070,855,00068,820,00062,215,00063,002,00085,000,000100,034,00072,583,00065,374,00060,634,000
Net income
-919k
L-95.72%
7,236,0003,044,0002,103,0001,784,0006,218,0002,846,0001,664,00010,345,0008,105,00012,709,0008,865,0009,241,00010,689,0003,356,0005,570,0006,800,0003,554,0004,865,000-21,457,000-919,000
CFO
3m
-63.84%
9,151,0004,862,00010,669,0003,581,0008,461,0004,506,00010,206,00015,031,00015,180,00032,003,00016,123,999774,00014,775,00011,098,00014,769,0006,065,000-8,634,0004,809,0009,132,0003,302,000
Dividend
Aug 05, 20260.005 SGD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Incorporated in Singapore in 1962, Chemical Industries (Far East) Limited functions as an investment holding entity primarily involved in the production and sale of chemicals across Singapore and Myanmar. Its operations are organized into two distinct divisions: Industrial Chemicals and Properties. Within its chemical arm, the company manufactures essential compounds such as sodium hypochlorite, chlorine, hydrochloric acid, and calcium hydroxide, vital for applications in water purification and the electronics sector. Beyond manufacturing, it also offers comprehensive distribution and logistics solutions for chemicals. Additionally, the firm oversees and leases commercial real estate. Completing its portfolio, it acts as a broad-based merchant, facilitating the import and export of a range of chemical products.
URL
http://www.cil.sg/
IPO date
Jan 02, 1979
Employees
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT